Bisphenol a exposure and the development of wheeze and lung function in children through age 5 years

Adam J Spanier1, Robert S Kahn2, Allen R Kunselman3

  • 1Department of Pediatrics, Penn State University Hershey Medical Center, Hershey, Pennsylvania2Department of Public Health Sciences, Penn State University Hershey Medical Center, Hershey, Pennsylvania3currently with the Department of Pediatrics, University.

JAMA Pediatrics
|October 7, 2014
PubMed

Insights

Prenatal exposure to Bisphenol A (BPA) is linked to reduced lung function and persistent wheeze in children. Postnatal BPA exposure did not show similar associations in this study.

Area of Science:

  • Environmental Health
  • Pediatric Respiratory Health
  • Endocrinology

Background:

  • Bisphenol A (BPA) is an endocrine-disrupting chemical with potential respiratory effects.
  • Previous studies suggest a link between BPA and wheezing in children, but effects on lung function and wheeze patterns in older children are less understood.

Purpose of the Study:

  • To investigate the association between Bisphenol A (BPA) exposure and lung function (FEV1).
  • To examine the relationship between BPA exposure and the occurrence and pattern of wheeze in children up to 5 years of age.

Main Methods:

  • A birth cohort study involving 398 mother-infant dyads.
  • Maternal urine samples collected during pregnancy and child urine samples annually to measure BPA exposure.
  • Parent-reported wheeze assessed every 6 months; lung function (FEV1) measured at ages 4 and 5.

Main Results:

  • Prenatal BPA exposure was associated with a significant decrease in predicted FEV1 at age 4.
  • Maternal BPA levels showed a marginal association with increased odds of wheezing and a significant association with persistent wheeze.
  • Childhood BPA exposure was not associated with FEV1 or wheeze.

Conclusions:

  • Prenatal exposure to Bisphenol A (BPA) is associated with impaired lung function and the development of persistent wheeze in children.
  • These findings highlight the potential impact of early-life environmental exposures on respiratory health.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
25
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
19
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
40
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
17
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.9K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K